Company
AVTX · CIK 0001534120
Acquisition (code M) of 12,394 shares at $9.88 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code M
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001810417-26-000023 · filed 2026-09-18 · View filing →
Sale of 12,394 shares at $16.3335 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 18, 2026
Source: SEC Form 4 · 0001810417-26-000023 · filed 2026-09-18 · View filing →
Acquisition (code M) of 10,185 shares at $8.04 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code M
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001810417-26-000021 · filed 2026-09-11 · View filing →
Sale of 10,185 shares at $17.6197 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code S
Traded Sep 10, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001810417-26-000021 · filed 2026-09-11 · View filing →
Acquisition (code M) of 679 shares at $8.04 per share.
Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code M
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001918845-26-000031 · filed 2026-09-01 · View filing →
Sale of 679 shares at $20 per share.
Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 28, 2026 · Disclosed Sep 1, 2026
Source: SEC Form 4 · 0001918845-26-000031 · filed 2026-09-01 · View filing →
Acquisition (code M) of 31,031 shares at $9.88 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 18, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001810417-26-000019 · filed 2026-08-19 · View filing →
Sale of 31,031 shares at $20.0549 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001810417-26-000019 · filed 2026-08-19 · View filing →
Acquisition (code M) of 37,945 shares at $9.88 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001810417-26-000019 · filed 2026-08-19 · View filing →
Acquisition (code M) of 2,876 shares at $9.88 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code M
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001810417-26-000019 · filed 2026-08-19 · View filing →
Sale of 37,945 shares at $19.8533 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001810417-26-000019 · filed 2026-08-19 · View filing →
Sale of 3,749 shares at $19.9419 per share.
Reporting Person Sullivan Christopher Ryan · Officer Title Chief Financial Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001810417-26-000019 · filed 2026-08-19 · View filing →
Acquisition (code M) of 1,000 shares at $12.65 per share.
Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code M
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001918845-26-000029 · filed 2026-08-19 · View filing →
Sale of 1,000 shares at $20 per share.
Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001918845-26-000029 · filed 2026-08-19 · View filing →
Sale of 2,655 shares at $19.5903 per share.
Reporting Person Riley Jennifer · Officer Title Chief Strategy Officer · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0002047607-26-000008 · filed 2026-08-12 · View filing →
Acquisition (code M) of 679 shares at $8.04 per share.
Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code M
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001918845-26-000026 · filed 2026-08-12 · View filing →
Sale of 679 shares at $20 per share.
Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001918845-26-000026 · filed 2026-08-12 · View filing →